Teva Shares Jump on Positive Copaxone Patent Ruling

24.06.2012 - Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...